SONX Sonendo, Inc.
Dental Equipment & Supplies · OTC · SEC CIK 1407973 · Fiscal year ends 12/31
Financial factors as of 2024-12-31 (2024Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY-4.1%
TTM net income YoY54.0%
TTM EPS YoY54.5%
Revenue 3-yr CAGR0.0%
Net income 3-yr CAGR—
Margins
Gross margin35.7%
Operating margin-88.5%
Net margin-84.4%
FCF margin-74.7%
EBITDA margin-87.6%
Returns
ROE-166.8%
ROA-51.2%
ROIC (approx.)-75.8%
Asset turnover0.61x
Leverage & solvency
Liabilities / assets83.4%
Debt / equity2.78x
Current ratio1.39x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.88x
Accruals ratio-6.2%
Payout ratio—
Capex / revenue0.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20242024-12-31 | FY20232023-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $33.20M | $34.63M |
| Cost of revenue | $19.86M | $29.96M |
| Gross profit | $11.84M | $4.67M |
| R&D expense | $6.76M | $10.44M |
| SG&A expense | $17.35M | $24.79M |
| Operating income | -$29.37M | -$59.27M |
| Interest expense | $5.47M | $6.46M |
| Pretax income | -$33.54M | -$62.46M |
| Income tax | $2,000 | $2,000 |
| Net income | -$28.03M | -$60.92M |
| EBITDA | -$29.08M | -$58.15M |
| EPS (basic) | -59.03 | -129.63 |
| EPS (diluted) | -59.03 | -129.63 |
| Weighted avg. shares (diluted) | 474,856 | 469,943 |
| Balance sheet | ||
| Cash & equivalents | $10.23M | $14.01M |
| Short-term investments | $1.40M | $32.77M |
| Receivables | $3.68M | $4.79M |
| Inventory | $10.21M | $11.07M |
| Current assets | $27.80M | $65.27M |
| PP&E, net | $0 | $664,000 |
| Goodwill | — | $8.45M |
| Intangibles | — | $661,000 |
| Total assets | $31.27M | $78.16M |
| Current liabilities | $19.94M | $35.32M |
| Short-term debt | $10.80M | $24.90M |
| Long-term debt | $3.64M | $12.47M |
| Total debt | $14.44M | $37.37M |
| Total liabilities | $26.07M | $49.74M |
| Shareholders' equity | $5.19M | $28.42M |
| Net debt | $4.21M | $23.36M |
| Shares outstanding | 427,330 | 317,737 |
| Cash flow statement | ||
| Operating cash flow | -$24.65M | -$46.06M |
| Capital expenditure | $161,000 | $929,000 |
| Free cash flow | -$24.81M | -$46.99M |
| Investing cash flow | $45.81M | $42.40M |
| Financing cash flow | -$24.95M | $4,000 |
| Depreciation & amortization | $288,000 | $1.12M |
| Stock-based compensation | $4.82M | $7.28M |
Free plan shows the latest 2 periods; Pro shows all 5 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.